DD01, a Dual GLP-1/Glucagon Agonist, in Metabolic Dysfunction–Associated Steatotic Liver Disease and Steatohepatitis: A Phase 2 Trial Top Line Results

SSRN Electronic Journal 2026 Preprint Open access

Read full text

Authors: Mazen Noureddin, Winston Dunn, Rashmee Patil, See PDF

DOI: 10.2139/ssrn.6034158

Cited by: 0

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Diabetes Treatment and Management Hepatocellular Carcinoma Treatment and Prognosis